← SynDRA
RIVASTIGMINE
SynDRA canonical compound SYN0001280 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | BCHE |
|---|
| Mechanism of action | Acetylcholinesterase inhibitor |
|---|
| Indication | Alzheimer's disease | Parkinson's Disease | senile dementia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- ACHE
- BCHE
- Ache
- Bche
- Chrne
- ache
Mechanisms of action (all sources)
- Acetylcholinesterase inhibitor
- ACHE MODULATOR
- ACHE INHIBITOR
- BCHE INHIBITOR
Drug classes
- Cholinesterase Inhibitors
- Central Nervous System Agents
- Cholinergic Agents
- Enzyme Inhibitors
- Neuroprotective Agents
- Neurotransmitter Agents
- Protective Agents
- Cholinesterase Inhibitor
ATC classes
- N06D · ANTI-DEMENTIA DRUGS
Cross-references
Synonyms
- prometax
- S-Rivastigmine
- rivastigmine tartrate
- rivastigmine hydrogen tartrate
- rivastigmine hexal
- exelon
- Rivastigmina
- ENA 713
- ENA-713D
- ONO-2540
- SDZ-212-713
- SDZ-212713
- Sdz-ena 713
- Exelon
- Rivastigmine 3m health care ltd
- Rivastigmine (transdermal patch)
- (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
- Nimvastid
- RIVASTIGMINE 1 A PHARMA
- RIVASTIGMINE 3M HEALTH CARE LTD
- Rivastigmine Teva
- PKI06M3IW0
- rivastigmine (ep monograph)
- Prometax
- m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
- rivastigmine (usp-rs)
- Rivastigmine sandoz
- SDZ 212-713
- rivastigmine (usp monograph)
- ENA 713 free base
- SDZ-ENA 713
- Rivastigmine Transdermal System
- CHEBI:8874
- rivastigminum
- Erastig
- Kerstipon
- Somniton
- Alzest
Reported adverse events
- Anxiety
- Dehydration
- Depression
- Dizziness
- Dyskinesia
- Fatigue
- Hallucination
- Headache
- Hypertension
- Insomnia
- Malaise
- Nausea
Look up RIVASTIGMINE in the interactive SynDRA portal →